tiprankstipranks
Trending News
More News >
Vitrolife AB (SE:VITR)
:VITR
Sweden Market
Advertisement

Vitrolife AB (VITR) Earnings Dates, Call Summary & Reports

Compare
1 Followers

Earnings Data

Report Date
Feb 03, 2026
Before Open (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
Last Year’s EPS
1.03
Same Quarter Last Year
Based on 0 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Oct 23, 2025|
% Change Since:
|
Earnings Call Sentiment|Neutral
The earnings call reflects a company that is navigating difficult macroeconomic conditions with strategic investments and strong growth in certain regions, particularly the Americas. However, challenges such as currency impacts, regional difficulties in China, and increased operating expenses weigh on the overall performance.
Company Guidance
In the Q3 2025 earnings call, Vitrolife provided detailed financial and operational guidance despite challenging macroeconomic conditions. The company achieved 5% organic growth in local currencies, excluding discontinued business, with sales totaling SEK 835 million. The gross margin remained stable at 58.9%, while EBITDA reached SEK 253 million, translating to a 30.3% EBITDA margin. Notably, the Americas region showed strong performance with an 11% sales increase in local currencies, contributing 33% of total sales. EMEA delivered sales of SEK 309 million with a 4% organic growth, and APAC recorded a 1% increase, marking its first positive quarter year-to-date. The company's operating cash flow was SEK 255 million, supported by effective working capital management. Looking forward, Vitrolife emphasized strategic investments in sales and marketing, particularly in the U.S., and continued focus on innovation and operational excellence to navigate the economic landscape.
Organic Growth Amid Challenges
Vitrolife delivered a 5% organic growth in local currencies, excluding discontinued business, despite facing macroeconomic and geopolitical challenges in the reproductive health industry.
Strong Performance in Americas
Sales in the Americas increased by 11% in local currencies with strong growth across the entire portfolio and in all markets, marking the strongest quarter in 11 quarters.
Stable Gross and EBITDA Margins
Gross margin slightly increased to 58.9%, and EBITDA was SEK 253 million, with an EBITDA margin of 30.3%, showing resilience despite negative currency impacts.
Positive Developments in EMEA and APAC
EMEA showed a 4% growth in local currencies, excluding discontinued business, and APAC recorded its first positive quarter of the year with 1% organic growth.
Operational Cash Flow
The company reported a strong operating cash flow of SEK 255 million, benefiting from positive contributions from net working capital.

Vitrolife AB (SE:VITR) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

SE:VITR Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 03, 2026
2025 (Q4)
- / -
1.03
Oct 23, 2025
2025 (Q3)
0.94 / 0.75
0.85-11.76% (-0.10)
Jul 17, 2025
2025 (Q2)
1.11 / 0.74
1.06-30.19% (-0.32)
Apr 24, 2025
2025 (Q1)
0.92 / 0.74
0.85-12.94% (-0.11)
Jan 30, 2025
2024 (Q4)
1.11 / 1.03
-30.86103.34% (+31.89)
Oct 24, 2024
2024 (Q3)
1.07 / 0.85
0.9-5.56% (-0.05)
Jul 17, 2024
2024 (Q2)
1.03 / 1.06
0.7835.90% (+0.28)
Apr 18, 2024
2024 (Q1)
0.93 / 0.85
0.7414.86% (+0.11)
Feb 02, 2024
2023 (Q4)
0.90 / -30.86
0.55-5710.91% (-31.41)
Oct 27, 2023
2023 (Q3)
0.77 / 0.90
0.812.50% (+0.10)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

SE:VITR Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Jul 17, 2025
kr151.30kr142.00-6.15%
Apr 24, 2025
kr155.26kr143.44-7.61%
Jan 30, 2025
kr226.53kr233.28+2.98%
Oct 24, 2024
kr234.47kr239.83+2.29%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Vitrolife AB (SE:VITR) report earnings?
Vitrolife AB (SE:VITR) is schdueled to report earning on Feb 03, 2026, Before Open (Confirmed).
    What is Vitrolife AB (SE:VITR) earnings time?
    Vitrolife AB (SE:VITR) earnings time is at Feb 03, 2026, Before Open (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Vitrolife AB stock?
          The P/E ratio of Vitrolife AB is N/A.
            What is SE:VITR EPS forecast?
            Currently, no data Available
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis